Breaking the Bones of the Cell
Two Studies Describe How Taxol Resistance Develops
By Anette Breindl
Thursday, March 3, 2011
Two groups of scientists led by researchers from Genentech Inc. and Beth Israel Deaconess Medical Center, respectively have reported on why some cancer cells are resistant to drugs, such as Taxol, that target microtubules. Such drugs are among the most widely prescribed chemotherapeutic agents.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.